Aimmune Therapeutics Announces Pricing of Initial Public Offering

BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. today announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. In addition, Aimmune has granted the underwriters a 30-day option to purchase up to an additional 1,499,999 shares of common stock at the same price. Aimmune’s common stock is expected to begin trading on The NASDAQ Global Select Market on Au


Print Friendly, PDF & Email

Share This

Share this post with your friends!